Rare diseases
Investigational molecules
Locations
Back to Italy81 clinical trials in Cuneo, Italy. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Study of AZD6793 tablets to reduce flare-ups in adults with moderate to very severe chronic obstructive pulmonary disease (COPD)
ItalyPhase III trial evaluating ianalumab with background drug combination in patients with Sjögren's disease
ItalyRamantamig (JNJ-79635322) with drug combination versus standard therapy in newly diagnosed multiple myeloma patients not eligible for stem cell transplant
ItalyStudy of Tirabrutinib, Rituximab, and Temozolomide in Patients with Relapsed/Refractory Primary Central Nervous System Lymphoma
ItalyLong-Term Study of Imeroprubart in Adults With Graves' Disease
ItalyStudy of IMVT-1402 Treatment for Adults with Graves' Disease
ItalyStudy of XELOX chemotherapy with or without dostarlimab after chemoradiation in patients with locally advanced rectal cancer
ItalyStudy comparing daratumumab, lenalidomide and dexamethasone followed by linvoseltamab versus continued initial treatment in newly diagnosed multiple myeloma patients
ItalyStudy Comparing Olaparib and Chemotherapy for Patients with Recurrent Ovarian Cancer After Surgery
ItalyStudy of gemtuzumab ozogamicin with chemotherapy for adults aged 18-60 with newly diagnosed favorable-intermediate-risk acute myeloid leukemia
ItalyStudy of Atezolizumab, Carboplatin, and Nab-Paclitaxel for Patients with Metastatic Triple-Negative PD-L1 Positive Breast Cancer
ItalyStudy on Olaparib for Maintenance Therapy in Patients with Newly Diagnosed Advanced Ovarian, Fallopian Tube, and Peritoneal Cancer
ItalyThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking trials focusing on Acute Myeloid Leukemia (AML) and various lymphomas, testing innovative combination therapies and transplantation approaches.
Studies evaluating targeted therapies for Multiple Myeloma and Chronic Lymphocytic Leukemia.
Research examining innovative treatments for breast cancer, including trials for triple-negative and hormone-responsive subtypes.
Advanced studies in ovarian cancer and lung cancer, exploring novel therapeutic approaches.
Investigating immunotherapy approaches across multiple cancer types, with focus on combination strategies.
Evaluation of novel drug combinations and treatment sequences for optimal patient outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
